In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...
Continuous use of GLP-1 receptor agonists in adults with type 2 diabetes was associated with a lower risk of major cardiovascular events compared with sulfonylureas, with benefits increasing over time ...
Patients on GLP-1 or GLP-1/GIP agonists had significant residual gastric volume if the medication was not held prior to upper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results